Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Lithuania,Austria,United Kingdom,Belgium,Sweden,Germany,Portugal,France,Netherlands,Australia - Promoter: nct
nct
Update Il y a 5 ans
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
The objectives of this program are: to further characterize the natural progression of MPS VI disease; to generate and disseminate information on the care and management of MPS VI patients to clinical and medical professionals; to provide a resource to physicians and patients by providing information for optimizing patient care based on aggregate data; to characterize the clinical response to long-term Naglazyme® (galsulfase) treatment; to further characterize the long-term safety of Naglazyme® treatment.
Country
Australia
,
Austria
,
Belgium
,
France
,
Germany
,
Ireland
,
Italy
,
Lithuania
,
Netherlands
,
Portugal
,
Sweden
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Opened trial
More information
1